Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank93
3Y CAGR+480.1%
5Y CAGR+12.2%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
+480.1%/yr
vs -30.6%/yr prior
5Y CAGR
+12.2%/yr
Recent acceleration
Acceleration
+510.8pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 135.96% |
| 2024 | -40.39% |
| 2023 | -32.56% |
| 2022 | 0.70% |
| 2021 | -14.05% |
| 2020 | 76.33% |
| 2019 | 128.33% |
| 2018 | 3.01% |
| 2017 | -29.05% |
| 2016 | -18.47% |